These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7912411)

  • 21. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system.
    De Mello WC
    J Mol Cell Cardiol; 2004 Aug; 37(2):431-8. PubMed ID: 15276013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential therapy of chronic heart failure].
    Riegger AJ
    Internist (Berl); 1993 Oct; 34(10):939-43. PubMed ID: 8225843
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiology and clinical spectrum of acute congestive heart failure.
    Shah M; Ali V; Lamba S; Abraham WT
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S2-6. PubMed ID: 12439355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs and renin].
    Zavagli G; Ricci G; Meduri P
    Clin Ter; 1982 Oct; 103(2):177-205. PubMed ID: 6129938
    [No Abstract]   [Full Text] [Related]  

  • 27. Limitations of current medical therapies for the treatment of heart failure.
    Miller LW
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S21-9. PubMed ID: 12776010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurohormonal activation in heart failure with reduced ejection fraction.
    Hartupee J; Mann DL
    Nat Rev Cardiol; 2017 Jan; 14(1):30-38. PubMed ID: 27708278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic heart failure--the epidemic of the 21st century].
    Czuriga I
    Orv Hetil; 2005 May; 146(20 Suppl 2):1075-87. PubMed ID: 15945236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological treatment of chronic heart failure in patients with renal failure].
    Stawicki S; Starczewska MH; Roik M; Opolski G
    Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
    [No Abstract]   [Full Text] [Related]  

  • 32. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
    Francis GS
    Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of atherosclerosis and cardiac cell dysfunction].
    Yonemochi H; Nakagawa M; Iwao T; Ito M
    Rinsho Byori; 1996 Nov; 44(11):1037-42. PubMed ID: 8953933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of advanced heart failure.
    Jessup M; Brozena S
    Cardiol Rev; 2000; 8(3):148-57. PubMed ID: 11174888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of heart failure. II. Therapy of chronic heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):36-8, 41-5. PubMed ID: 9280747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
    Ferrini R; Merlo L; Miragoli G
    Cardiologia; 1988 Jan; 33(1):49-53. PubMed ID: 2835159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.